AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $26,328,000 | +13.4% | 1,575,531 | -2.1% | 0.09% | -8.2% |
| Q1 2020 | $23,218,000 | -58.4% | 1,610,110 | -3.4% | 0.10% | -47.8% |
| Q4 2019 | $55,798,000 | +115.0% | 1,667,126 | +34.5% | 0.19% | +91.8% |
| Q3 2019 | $25,958,000 | +715.0% | 1,239,627 | +710.3% | 0.10% | +708.3% |
| Q2 2019 | $3,185,000 | -11.3% | 152,993 | -4.7% | 0.01% | -14.3% |
| Q1 2019 | $3,589,000 | +68.5% | 160,572 | +80.3% | 0.01% | +40.0% |
| Q4 2018 | $2,130,000 | +36.1% | 89,053 | +55.2% | 0.01% | +66.7% |
| Q3 2018 | $1,565,000 | -37.2% | 57,367 | -38.1% | 0.01% | -45.5% |
| Q2 2018 | $2,492,000 | – | 92,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |